Log in to save to my catalogue

Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated pro...

Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated pro...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_88134b10070c4d0282bcd632eff9704b

Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein/peptide antibodies test results

About this item

Full title

Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein/peptide antibodies test results

Publisher

England: EULAR

Journal title

Rheumatic & musculoskeletal diseases open, 2022-03, Vol.8 (1), p.e002099

Language

English

Formats

Publication information

Publisher

England: EULAR

More information

Scope and Contents

Contents

BackgroundRheumatoid factor (RF) and anti-citrullinated protein/peptide antibodies (ACPA) are important biomarkers for diagnosis of rheumatoid arthritis (RA). However, there is poor harmonisation of RF and ACPA assays. The aim of this study was to refine RF and ACPA interpretation across commercial assays.Materials and methodsSix total RF isotype-n...

Alternative Titles

Full title

Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein/peptide antibodies test results

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_88134b10070c4d0282bcd632eff9704b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_88134b10070c4d0282bcd632eff9704b

Other Identifiers

ISSN

2056-5933

E-ISSN

2056-5933

DOI

10.1136/rmdopen-2021-002099